USV Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glycomet Trio 1 Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glycomet Trio 1 Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glycomet Trio 1 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glycomet Trio 1 Tablet SR.
Glycomet Trio 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glycomet Trio 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glycomet Trio 1 Tablet SR is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glycomet Trio 1 Tablet SR is a combination medication containing Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, along with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, Metformin lowers glucose production in the liver and improves insulin sensitivity, and Voglibose reduces postprandial glucose levels. This medication is not suitable for treating type 1 DM.
Common side effects of Glycomet Trio 1 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor or healthcare provider.
Glycomet Trio 1 Tablet SR should be avoided in patients with known allergies to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis. Consult your doctor or healthcare provider before taking this medication if you have any of these conditions.
No, it is not recommended to consume alcohol while taking Glycomet Trio 1 Tablet SR. This may increase the risk of hypoglycemia and lactic acidosis. Consult your doctor or healthcare provider for personalized advice on alcohol consumption while taking this medication.
Yes, Glycomet Trio 1 Tablet SR can cause hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. Regular monitoring of blood sugar levels is crucial to prevent and manage hypoglycemia. Always carry glucose tablets, honey, or fruit juice with you to treat hypoglycemia.
Store Glycomet Trio 1 Tablet SR in its original packaging, tightly closed. Dispose of unused medication and ensure it is not consumed by pets, children, or other individuals.